AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DIMERIX LTD

0.445

0.000

Volume:168.62K

Turnover:75.13K

Market Cap:267.18M

PE:-18.82

High:0.450

Open:0.445

Low:0.440

Close:0.445

52wk High:0.785

52wk Low:0.340

Shares:600.40M

Float Shares:467.70M

Volume Ratio:1.05

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.024

EPS(LYR):-0.024

ROE:-83.97%

ROA:-32.13%

PB:19.97

PE(LYR):-18.82

Loading ...

Overview Company News Filings

Company Profile

Company Name:

DIMERIX LTD

Exchange:

ASX

Establishment Date:

- -

Employees:

- -

Office Location:

425 Smith Street,Fitzroy,Victoria,Australia

Website:

http://dimerix.com

Zip Code:

3065

Phone:

Fax:

61 8 9388 8256

Introduction:

Dimerix Limited, a clinical stage biotechnology company, develops and commercializes new therapies in the area of unmet medical needs. Its lead product candidate is DMX-200, which is in Phase II clinical trial for the treatment of diabetic kidney diseases and focal segmental glomerulosclerosis. The company is headquartered in Fitzroy, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DXB.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DXB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","market":"AU","secType":"STK","nameCN":"DIMERIX LTD","latestPrice":0.445,"timestamp":1771980166212,"preClose":0.445,"halted":0,"volume":168616,"delay":0,"changeRate":0,"nameEN":"DIMERIX LTD","floatShares":467696880,"shares":600396776,"eps":-0.023645,"marketStatus":"Trading","change":0,"latestTime":"02-25 11:45:57 AEDT","open":0.445,"high":0.45,"low":0.44,"amount":75134,"amplitude":0.022472,"askPrice":0.45,"askSize":12333,"bidPrice":0.445,"bidSize":36445,"shortable":3,"etf":0,"ttmEps":-0.023645,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771995600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.445,"openAndCloseTimeList":[[1771974000000,1771995600000]],"volumeRatio":1.053424,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","floatShares":467696880,"roa":"-32.13%","roe":"-83.97%","lyrEps":-0.023645,"volumeRatio":1.053424,"shares":600396776,"dividePrice":0,"high":0.45,"amplitude":0.022472,"preClose":0.445,"low":0.44,"week52Low":0.34,"pbRate":"19.97","psRate":"47.82","week52High":0.785,"institutionHeld":0,"latestPrice":0.445,"committee":0.494321,"eps":-0.023645,"divideRate":0,"volume":168616,"delay":0,"ttmEps":-0.023645,"open":0.445,"prevYearClose":0.55,"prevWeekClose":0.475,"prevMonthClose":0.505,"prevQuarterClose":0.55,"fiveDayClose":0.475,"twentyDayClose":0.525,"sixtyDayClose":0.495,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DXB.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DXB.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":23928564,"address":"425 Smith Street,Fitzroy,Victoria,Australia","zipCode":"3065","officePhone":"1300 813 321","officeFax":"61 8 9388 8256"},"stockCompanyDetail":{"websiteUrl":"http://dimerix.com","stockEarnings":[{"period":"1week","weight":-0.0729},{"period":"1month","weight":-0.1442},{"period":"3month","weight":-0.0729},{"period":"6month","weight":0},{"period":"1year","weight":-0.1359},{"period":"ytd","weight":-0.1909}],"compareEarnings":[{"period":"1week","weight":0.0133},{"period":"1month","weight":0.02},{"period":"3month","weight":0.0471},{"period":"6month","weight":0.0696},{"period":"1year","weight":0.217},{"period":"ytd","weight":0.0222}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Dimerix Limited, a clinical stage biotechnology company, develops and commercializes new therapies in the area of unmet medical needs. Its lead product candidate is DMX-200, which is in Phase II clinical trial for the treatment of diabetic kidney diseases and focal segmental glomerulosclerosis. The company is headquartered in Fitzroy, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.181818,"avgChangeRate":-0.098331},{"month":2,"riseRate":0.5,"avgChangeRate":0.059355},{"month":3,"riseRate":0.4,"avgChangeRate":0.044676},{"month":4,"riseRate":0.3,"avgChangeRate":0.035547},{"month":5,"riseRate":0.5,"avgChangeRate":0.05},{"month":6,"riseRate":0.8,"avgChangeRate":0.163438},{"month":7,"riseRate":0.272727,"avgChangeRate":0.065367},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.063764},{"month":9,"riseRate":0.363636,"avgChangeRate":0.171129},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.090222},{"month":11,"riseRate":0.272727,"avgChangeRate":0.028595},{"month":12,"riseRate":0.454545,"avgChangeRate":0.04297}],"exchange":"ASX","name":"DIMERIX LTD","nameEN":"DIMERIX LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"DXB.AU\",market:\"AU\",,,undefined,":null}}